Correlation Between Mineralys Therapeutics, and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Revolution Medicines, you can compare the effects of market volatilities on Mineralys Therapeutics, and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Revolution Medicines.
Diversification Opportunities for Mineralys Therapeutics, and Revolution Medicines
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mineralys and Revolution is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Revolution Medicines go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Revolution Medicines
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Revolution Medicines. In addition to that, Mineralys Therapeutics, is 2.17 times more volatile than Revolution Medicines. It trades about -0.14 of its total potential returns per unit of risk. Revolution Medicines is currently generating about -0.03 per unit of volatility. If you would invest 4,400 in Revolution Medicines on November 2, 2024 and sell it today you would lose (93.00) from holding Revolution Medicines or give up 2.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Revolution Medicines
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Revolution Medicines |
Mineralys Therapeutics, and Revolution Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Revolution Medicines
The main advantage of trading using opposite Mineralys Therapeutics, and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.| Mineralys Therapeutics, vs. Dine Brands Global | Mineralys Therapeutics, vs. El Pollo Loco | Mineralys Therapeutics, vs. Flanigans Enterprises | Mineralys Therapeutics, vs. Saia Inc |
| Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |